TickerFactsScreenerDevelopers

IGC Pharma, Inc. (IGC) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $842.9K2011: $1.58M2012: $562.9K2013: $1.06M2014: $1.03M2015: $824.5K2016: $1.49M2017: $538.0K2018: $1.66M2019: $25.61M2020: $7.26M2021: $14.55M2022: $10.46M2023: $3.20M2024: $1.20M2025: $900.0K$900.0K
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$900.0K-24.9%
2024$1.20M-62.5%
2023$3.20M-69.4%
2022$10.46M-28.1%
2021$14.55M+100.4%
2020$7.26M-71.7%
2019$25.61M+1444.6%
2018$1.66M+208.2%
2017$538.0K-63.9%
2016$1.49M+80.8%
2015$824.5K-19.7%
2014$1.03M-3.6%
2013$1.06M+89.1%
2012$562.9K-64.4%
2011$1.58M+87.8%
2010$842.9K—